General Information
Product name
Leucovorin Calcium Inj. USP
Manufacturer Name
Hospital Products Division
Emergency telephone
1-847-937-7970, 1-800-424-9300
Icons in SDS
Company Information
company name
Hospital Products Division
Section 2
Principle Routes of Exposure
Skin: Unlikely Inhalation: Unlikely Ingestion: Unlikely 3. HAZARDS INFORMATION, continued ----------------------- INGESTION RATING: N/D SKIN ABSORPTION RATING: N/D INHALATION RATING: N/D CORROSIVENESS RATING: N/D SKIN CONTACT RATING: N/D SKIN SENSITIZATION RATING: N/D EYE CONTACT RATING: N/D TARGET ORGANS: Possibly gastrointestinal tract, central nervous system CARCINOGENICITY RATING NTP N/L IARC N/L OSHA N/L ACGIH: N/L None SIGNS AND SYMPTOMS: N/D. In clinical use doses of 15 mg daily for one month or more have caused gastrointestinal distress, altered sleep, difficulty in concentrating, irritability, overactivity, excitement, mental depression, confusion and impaired judgement. Fever has occurred after parenteral administration of leucovorin calcium. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: N/D. Data suggest undiagnosed anemias, since improvement of blood picture may mask neurological complications of pernicious anemia.
